Danahervs.Illumina
DHR vs ILMN · both in Life science tools, part of the Medicine, pharma & life science value chain: Instruments, reagents and equipment for research, development and production.
Danaher is about 4.9× larger than Illumina by market cap; Illumina trades at the lower P/E (33.7 vs 38.1); year to date, Illumina leads (+45.0% vs −13.0%).
Side by side
| DHR | ILMN | |
|---|---|---|
| Market cap | $141B | $28.8B |
| Price | $199.05 | $190.20 |
| Today | +1.6% | −1.8% |
| Return YTD | −13.0% | +45.0% |
| Return 1Y | −3.1% | +90.1% |
| P/E | 38.1 | 33.7 |
| P/S | 5.7 | 6.6 |
| P/B | 2.7 | 10.8 |
Data as of 2026-07-11 · updates daily after U.S. close
The two companies
DanaherDHR
American group focused on life science and diagnostics — bioprocessing (Cytiva), molecular diagnostics and laboratory solutions.
Full DHR profile →IlluminaILMN
American leader in DNA sequencing — instruments and consumables used in research and clinical genomics.
Full ILMN profile →More comparisons in Life science tools
See where DHR and ILMN sit in the full Medicine, pharma & life science map — every segment from suppliers to end markets.Open the Life science value chain →